Correspondence
Concerns about medicinal cannabis
AMA Queensland, the Royal Australian and New Zealand College of Psychiatrists and the Pharmacy Guild, Queensland have written to the Therapeutic Goods Administration raising concerns about medicinal cannabis.
AMA Queensland, the Royal Australian and New Zealand College of Psychiatrists and the Pharmacy Guild, Queensland have written to the Therapeutic Goods Administration raising concerns about medicinal cannabis.
On 29 November 2024, Deputy Secretary of the Health Products Regulation Group, Professor Anthony Lawler, responded to our letter.
